The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Commercializing Biomarkers-Global Market Insights and Sales Trends 2025
Synopsis
Biomarkers measure cellular, biochemical or molecular changes in human tissues, cells or fluids, and contribute to future diagnostics and treatment. The development of biomarkers is time consuming and expensive, requiring the involvement of industry from early stages to better direct the research.
The global Commercializing Biomarkers market size is expected to reach US$ 29560 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Commercializing Biomarkers in various end use industries. The expanding demands from the Oncology, Cardiology, Neurology and Others, are propelling Commercializing Biomarkers market. Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Commercializing Biomarkers market, driven by demand from China, the second largest economy with some signs of stabilising, the Commercializing Biomarkers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Commercializing Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Commercializing Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Commercializing Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Commercializing Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Commercializing Biomarkers covered in this report include Roche, Dako (Agilent Technologies), Merck, BD, Abbott, Genesys Biolabs (20/20GeneSystems), Affymetrix, Agendia and ALMAC, etc.
The global Commercializing Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI
Global Commercializing Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Commercializing Biomarkers market, Segment by Type:
Consumables
Services
Software
Global Commercializing Biomarkers market, by Application
Oncology
Cardiology
Neurology
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Commercializing Biomarkers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Commercializing Biomarkers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Biomarkers measure cellular, biochemical or molecular changes in human tissues, cells or fluids, and contribute to future diagnostics and treatment. The development of biomarkers is time consuming and expensive, requiring the involvement of industry from early stages to better direct the research.
The global Commercializing Biomarkers market size is expected to reach US$ 29560 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Commercializing Biomarkers in various end use industries. The expanding demands from the Oncology, Cardiology, Neurology and Others, are propelling Commercializing Biomarkers market. Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Commercializing Biomarkers market, driven by demand from China, the second largest economy with some signs of stabilising, the Commercializing Biomarkers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Commercializing Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Commercializing Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Commercializing Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Commercializing Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Commercializing Biomarkers covered in this report include Roche, Dako (Agilent Technologies), Merck, BD, Abbott, Genesys Biolabs (20/20GeneSystems), Affymetrix, Agendia and ALMAC, etc.
The global Commercializing Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI
Global Commercializing Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Commercializing Biomarkers market, Segment by Type:
Consumables
Services
Software
Global Commercializing Biomarkers market, by Application
Oncology
Cardiology
Neurology
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Commercializing Biomarkers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Commercializing Biomarkers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Commercializing Biomarkers Market Overview
1.1 Commercializing Biomarkers Product Overview
1.2 Commercializing Biomarkers Market Segment by Type
1.2.1 Consumables
1.2.2 Services
1.2.3 Software
1.3 Global Commercializing Biomarkers Market Size by Type
1.3.1 Global Commercializing Biomarkers Market Size Overview by Type (2018-2029)
1.3.2 Global Commercializing Biomarkers Historic Market Size Review by Type (2018-2023)
1.3.3 Global Commercializing Biomarkers Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Commercializing Biomarkers Sales Breakdown by Type (2018-2023)
1.4.2 Europe Commercializing Biomarkers Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Commercializing Biomarkers Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Commercializing Biomarkers Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Commercializing Biomarkers Sales Breakdown by Type (2018-2023)
2 Global Commercializing Biomarkers Market Competition by Company
2.1 Global Top Players by Commercializing Biomarkers Sales (2018-2023)
2.2 Global Top Players by Commercializing Biomarkers Revenue (2018-2023)
2.3 Global Top Players by Commercializing Biomarkers Price (2018-2023)
2.4 Global Top Manufacturers Commercializing Biomarkers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Commercializing Biomarkers Market Competitive Situation and Trends
2.5.1 Commercializing Biomarkers Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Commercializing Biomarkers Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Commercializing Biomarkers as of 2022)
2.7 Date of Key Manufacturers Enter into Commercializing Biomarkers Market
2.8 Key Manufacturers Commercializing Biomarkers Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Commercializing Biomarkers Status and Outlook by Region
3.1 Global Commercializing Biomarkers Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Commercializing Biomarkers Historic Market Size by Region
3.2.1 Global Commercializing Biomarkers Sales in Volume by Region (2018-2023)
3.2.2 Global Commercializing Biomarkers Sales in Value by Region (2018-2023)
3.2.3 Global Commercializing Biomarkers Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Commercializing Biomarkers Forecasted Market Size by Region
3.3.1 Global Commercializing Biomarkers Sales in Volume by Region (2024-2029)
3.3.2 Global Commercializing Biomarkers Sales in Value by Region (2024-2029)
3.3.3 Global Commercializing Biomarkers Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Commercializing Biomarkers by Application
4.1 Commercializing Biomarkers Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Neurology
4.1.4 Others
4.2 Global Commercializing Biomarkers Market Size by Application
4.2.1 Global Commercializing Biomarkers Market Size Overview by Application (2018-2029)
4.2.2 Global Commercializing Biomarkers Historic Market Size Review by Application (2018-2023)
4.2.3 Global Commercializing Biomarkers Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Commercializing Biomarkers Sales Breakdown by Application (2018-2023)
4.3.2 Europe Commercializing Biomarkers Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Commercializing Biomarkers Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Commercializing Biomarkers Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Commercializing Biomarkers Sales Breakdown by Application (2018-2023)
5 North America Commercializing Biomarkers by Country
5.1 North America Commercializing Biomarkers Historic Market Size by Country
5.1.1 North America Commercializing Biomarkers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Commercializing Biomarkers Sales in Volume by Country (2018-2023)
5.1.3 North America Commercializing Biomarkers Sales in Value by Country (2018-2023)
5.2 North America Commercializing Biomarkers Forecasted Market Size by Country
5.2.1 North America Commercializing Biomarkers Sales in Volume by Country (2024-2029)
5.2.2 North America Commercializing Biomarkers Sales in Value by Country (2024-2029)
6 Europe Commercializing Biomarkers by Country
6.1 Europe Commercializing Biomarkers Historic Market Size by Country
6.1.1 Europe Commercializing Biomarkers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Commercializing Biomarkers Sales in Volume by Country (2018-2023)
6.1.3 Europe Commercializing Biomarkers Sales in Value by Country (2018-2023)
6.2 Europe Commercializing Biomarkers Forecasted Market Size by Country
6.2.1 Europe Commercializing Biomarkers Sales in Volume by Country (2024-2029)
6.2.2 Europe Commercializing Biomarkers Sales in Value by Country (2024-2029)
7 Asia-Pacific Commercializing Biomarkers by Region
7.1 Asia-Pacific Commercializing Biomarkers Historic Market Size by Region
7.1.1 Asia-Pacific Commercializing Biomarkers Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Commercializing Biomarkers Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Commercializing Biomarkers Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Commercializing Biomarkers Forecasted Market Size by Region
7.2.1 Asia-Pacific Commercializing Biomarkers Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Commercializing Biomarkers Sales in Value by Region (2024-2029)
8 Latin America Commercializing Biomarkers by Country
8.1 Latin America Commercializing Biomarkers Historic Market Size by Country
8.1.1 Latin America Commercializing Biomarkers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Commercializing Biomarkers Sales in Volume by Country (2018-2023)
8.1.3 Latin America Commercializing Biomarkers Sales in Value by Country (2018-2023)
8.2 Latin America Commercializing Biomarkers Forecasted Market Size by Country
8.2.1 Latin America Commercializing Biomarkers Sales in Volume by Country (2024-2029)
8.2.2 Latin America Commercializing Biomarkers Sales in Value by Country (2024-2029)
9 Middle East and Africa Commercializing Biomarkers by Country
9.1 Middle East and Africa Commercializing Biomarkers Historic Market Size by Country
9.1.1 Middle East and Africa Commercializing Biomarkers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Commercializing Biomarkers Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Commercializing Biomarkers Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Commercializing Biomarkers Forecasted Market Size by Country
9.2.1 Middle East and Africa Commercializing Biomarkers Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Commercializing Biomarkers Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Commercializing Biomarkers Products Offered
10.1.5 Roche Recent Development
10.2 Dako (Agilent Technologies)
10.2.1 Dako (Agilent Technologies) Company Information
10.2.2 Dako (Agilent Technologies) Introduction and Business Overview
10.2.3 Dako (Agilent Technologies) Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Dako (Agilent Technologies) Commercializing Biomarkers Products Offered
10.2.5 Dako (Agilent Technologies) Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Commercializing Biomarkers Products Offered
10.3.5 Merck Recent Development
10.4 BD
10.4.1 BD Company Information
10.4.2 BD Introduction and Business Overview
10.4.3 BD Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BD Commercializing Biomarkers Products Offered
10.4.5 BD Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Abbott Commercializing Biomarkers Products Offered
10.5.5 Abbott Recent Development
10.6 Genesys Biolabs (20/20GeneSystems)
10.6.1 Genesys Biolabs (20/20GeneSystems) Company Information
10.6.2 Genesys Biolabs (20/20GeneSystems) Introduction and Business Overview
10.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Products Offered
10.6.5 Genesys Biolabs (20/20GeneSystems) Recent Development
10.7 Affymetrix
10.7.1 Affymetrix Company Information
10.7.2 Affymetrix Introduction and Business Overview
10.7.3 Affymetrix Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Affymetrix Commercializing Biomarkers Products Offered
10.7.5 Affymetrix Recent Development
10.8 Agendia
10.8.1 Agendia Company Information
10.8.2 Agendia Introduction and Business Overview
10.8.3 Agendia Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Agendia Commercializing Biomarkers Products Offered
10.8.5 Agendia Recent Development
10.9 ALMAC
10.9.1 ALMAC Company Information
10.9.2 ALMAC Introduction and Business Overview
10.9.3 ALMAC Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ALMAC Commercializing Biomarkers Products Offered
10.9.5 ALMAC Recent Development
10.10 Arrayit
10.10.1 Arrayit Company Information
10.10.2 Arrayit Introduction and Business Overview
10.10.3 Arrayit Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Arrayit Commercializing Biomarkers Products Offered
10.10.5 Arrayit Recent Development
10.11 Biocartic
10.11.1 Biocartic Company Information
10.11.2 Biocartic Introduction and Business Overview
10.11.3 Biocartic Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Biocartic Commercializing Biomarkers Products Offered
10.11.5 Biocartic Recent Development
10.12 BG Medicine
10.12.1 BG Medicine Company Information
10.12.2 BG Medicine Introduction and Business Overview
10.12.3 BG Medicine Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.12.4 BG Medicine Commercializing Biomarkers Products Offered
10.12.5 BG Medicine Recent Development
10.13 KEGG EXPRESSION Database
10.13.1 KEGG EXPRESSION Database Company Information
10.13.2 KEGG EXPRESSION Database Introduction and Business Overview
10.13.3 KEGG EXPRESSION Database Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.13.4 KEGG EXPRESSION Database Commercializing Biomarkers Products Offered
10.13.5 KEGG EXPRESSION Database Recent Development
10.14 Thermo Fisher
10.14.1 Thermo Fisher Company Information
10.14.2 Thermo Fisher Introduction and Business Overview
10.14.3 Thermo Fisher Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Thermo Fisher Commercializing Biomarkers Products Offered
10.14.5 Thermo Fisher Recent Development
10.15 BGI
10.15.1 BGI Company Information
10.15.2 BGI Introduction and Business Overview
10.15.3 BGI Commercializing Biomarkers Sales, Revenue and Gross Margin (2018-2023)
10.15.4 BGI Commercializing Biomarkers Products Offered
10.15.5 BGI Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Commercializing Biomarkers Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Commercializing Biomarkers Industrial Chain Analysis
11.4 Commercializing Biomarkers Market Dynamics
11.4.1 Commercializing Biomarkers Industry Trends
11.4.2 Commercializing Biomarkers Market Drivers
11.4.3 Commercializing Biomarkers Market Challenges
11.4.4 Commercializing Biomarkers Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Commercializing Biomarkers Distributors
12.3 Commercializing Biomarkers Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
